Nicolet Bankshares’s Vertex Pharmaceuticals VRTX Stock Holding History

Nicolet Bankshares’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$740K	Buy	1,439 +22	+2%	+$9.75K	0.02%	352
2026 Q1	$633K	Buy	1,417 +800	+130%	+$373K	0.02%	358
2025 Q4	$280K	Hold	617	–	–	0.04%	187
2025 Q3	$242K	Hold	617	–	–	0.04%	197
2025 Q2	$275K	Hold	617	–	–	0.05%	185
2025 Q1	$299K	Sell	617 -30	-5%	-$14K	0.06%	167
2024 Q4	$261K	Hold	647	–	–	0.06%	173
2024 Q3	$301K	Hold	647	–	–	0.07%	173
2024 Q2	$303K	Hold	647	–	–	0.08%	172
2024 Q1	$270K	Sell	647 -42	-6%	-$17.8K	0.07%	188
2023 Q4	$280K	Sell	689 -15	-2%	-$5.54K	0.08%	178
2023 Q3	$245K	Hold	704	–	–	0.08%	169
2023 Q2	$248K	Sell	704 -22	-3%	-$7.41K	0.07%	178
2023 Q1	$229K	Sell	726 -143	-16%	-$42.9K	0.07%	180
2022 Q4	$251K	Sell	869 -37	-4%	-$11.3K	0.09%	169
2022 Q3	$262K	Sell	906 -225	-20%	-$64.7K	0.07%	151
2022 Q2	$319K	Buy	1,131 +229	+25%	+$61.3K	0.08%	149
2022 Q1	$235K	Buy	+902	New	+$214K	0.05%	192

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nicolet Bankshares's VRTX Position: Q2 2026 in Review

Nicolet Bankshares increased its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, buying an estimated $9.75K and bringing the position to 1,439 shares worth $740K. The position accounts for 0.02% of the portfolio, ranked #352.

Nicolet Bankshares first reported a position in VRTX in Q1 2022 and has held it in 18 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Nicolet Bankshares held 1,439 shares of Vertex Pharmaceuticals worth $740K as of Q2 2026.
Nicolet Bankshares bought 22 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.75K.
Vertex Pharmaceuticals made up 0.02% of Nicolet Bankshares's portfolio in Q2 2026, its #352 holding.
Nicolet Bankshares first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.